Healthcare -
Biotechnology - NASDAQ - GB
$ 69.63
3.74 %
$ 737 M
Market Cap
-32.24
P/E
VRNA - CAPITAL EXPENDITURES
Capital Expenditures VRNA - Verona Pharma plc
4.07
LAST VALUE
41.43%
2 YEAR CAGR
14.87%
5 YEAR CAGR
7.18%
10 YEAR CAGR